McKinsey Settles Oxy Accusations for 573 Million

  • Post author:
  • Post category:big pharma
  • Reading time:3 mins read

McKinsey, a consulting firm that worked for Purdue Pharma, Oxycontin’s creator, has been under the microscope. This week, they agreed to pay the government 574 million dollars for their actions that helped cause the opioid epidemic. The company worked with Purdue to create new strategies meant to “turbocharge sales” and admitted no harm but agreed to pay out the settlement. California Attorney General Xavier Becerra said the firm had been “part of a machine that… destroyed lives”.

The Accusations Against McKinsey

McKinsey is accused of advising Purdue to pressure doctors through sales calls, especially targeting doctors who were already known to be “high-level prescribers.” In doing so, they also asked sales associates to be careful to subvert the authorities. Their goal was simply to help doctors avoid prescribing limits that states were trying to uphold.

When higher-ups at McKinsey realized …

Continue ReadingMcKinsey Settles Oxy Accusations for 573 Million

Oxycontin Makers Sink Claws Into China

A report has come out detailing the marketing moves that Purdue Pharma, the drugmaker responsible for Oxycontin and other variations of opioid, has moved on to China. Of course, it’s no big secret that companies like food and pharmaceutical makers take their wares overseas to new markets.

What’s unusual about Purdue’s business moves is that the behavior that cost billions of dollars in US lawsuits is now being deployed in China.

Boosting Sales and Breaking Laws in China

Stat News claims that when sales began to crash due to the opioid crisis, the Sacklers and their subsidiaries set their eyes on the global market. In China, Purdue’s international pharma dealer, Mundipharma, pushed for profits over ethics without fail. While the profit scheme unraveled very publicly in the US courts, quietly, Purdue Pharma began marketing elsewhere.

Current and former employees told …

Continue ReadingOxycontin Makers Sink Claws Into China